U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H7O6P
Molecular Weight 218.1006
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FOSFOSAL

SMILES

OC(=O)C1=C(OP(O)(O)=O)C=CC=C1

InChI

InChIKey=FFKUDWZICMJVPA-UHFFFAOYSA-N
InChI=1S/C7H7O6P/c8-7(9)5-3-1-2-4-6(5)13-14(10,11)12/h1-4H,(H,8,9)(H2,10,11,12)

HIDE SMILES / InChI

Molecular Formula C7H7O6P
Molecular Weight 218.1006
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/3264273 | https://www.ncbi.nlm.nih.gov/pubmed/8008964 | https://www.ncbi.nlm.nih.gov/pubmed/7325717 | https://www.ncbi.nlm.nih.gov/pubmed/7012470 | https://www.ncbi.nlm.nih.gov/pubmed/3163974

Fosfosal (2-phosphonoxybenzoic acid) is a O-phosphorylated derivative of salicylic acid used in analgesic and anti-inflammatory therapy. Fosfosal showed analgesic effect in the acetic acid-induced writhing and in the hot plate tests in mice, and showed antiinflammatory effect in the xylene induced mice ears swelling and in acetic acid induced increased vascular permeability tests in mice. Both the effects had no significant differences between fosfosal and aspirin, but the former had less stomach irritation.

Originator

Sources: Compt. rend. (1923), 176, 1770-2.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
2.0 mM [IC50]
17.4 µM [Ki]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
276 μg/mL
2400 mg 3 times / day steady-state, oral
dose: 2400 mg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
FOSFOSAL plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Injectable self-curing bioactive acrylic-glass composites charged with specific anti-inflammatory/analgesic agent.
2004 May
Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy.
2006 Dec
Injectable and self-curing composites of acrylic/bioactive glass and drug systems. A histomorphometric analysis of the behaviour in rabbits.
2006 Mar
Patents

Patents

Sample Use Guides

The daily dose of fosfosal was 1 gram three times a day, once every 6-8 hours.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:38:44 UTC 2023
Edited
by admin
on Fri Dec 15 16:38:44 UTC 2023
Record UNII
124X2V25W4
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FOSFOSAL
INN   MART.   MI   WHO-DD  
INN  
Official Name English
DISODIUM SALICYLPHOSPHATE
INCI  
INCI  
Official Name English
FOSFOSAL [MART.]
Common Name English
SALICYLIC ACID PHOSPHATE DISODIUM SALT
Brand Name English
fosfosal [INN]
Common Name English
SALICYLIC ACID DIHYDROGEN PHOSPHATE
Systematic Name English
AYDOLID
Brand Name English
Fosfosal [WHO-DD]
Common Name English
NSC-46475
Code English
FOSFOSAL [MI]
Common Name English
DISODIUM SALICYLPHOSPHATE [INCI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C257
Created by admin on Fri Dec 15 16:38:44 UTC 2023 , Edited by admin on Fri Dec 15 16:38:44 UTC 2023
Code System Code Type Description
EPA CompTox
DTXSID9045394
Created by admin on Fri Dec 15 16:38:44 UTC 2023 , Edited by admin on Fri Dec 15 16:38:44 UTC 2023
PRIMARY
INN
4265
Created by admin on Fri Dec 15 16:38:44 UTC 2023 , Edited by admin on Fri Dec 15 16:38:44 UTC 2023
PRIMARY
DRUG CENTRAL
1244
Created by admin on Fri Dec 15 16:38:44 UTC 2023 , Edited by admin on Fri Dec 15 16:38:44 UTC 2023
PRIMARY
NCI_THESAURUS
C65760
Created by admin on Fri Dec 15 16:38:44 UTC 2023 , Edited by admin on Fri Dec 15 16:38:44 UTC 2023
PRIMARY
CAS
6064-83-1
Created by admin on Fri Dec 15 16:38:44 UTC 2023 , Edited by admin on Fri Dec 15 16:38:44 UTC 2023
PRIMARY
ChEMBL
CHEMBL287275
Created by admin on Fri Dec 15 16:38:44 UTC 2023 , Edited by admin on Fri Dec 15 16:38:44 UTC 2023
PRIMARY
FDA UNII
124X2V25W4
Created by admin on Fri Dec 15 16:38:44 UTC 2023 , Edited by admin on Fri Dec 15 16:38:44 UTC 2023
PRIMARY
ECHA (EC/EINECS)
227-993-5
Created by admin on Fri Dec 15 16:38:44 UTC 2023 , Edited by admin on Fri Dec 15 16:38:44 UTC 2023
PRIMARY
PUBCHEM
3418
Created by admin on Fri Dec 15 16:38:44 UTC 2023 , Edited by admin on Fri Dec 15 16:38:44 UTC 2023
PRIMARY
SMS_ID
100000080459
Created by admin on Fri Dec 15 16:38:44 UTC 2023 , Edited by admin on Fri Dec 15 16:38:44 UTC 2023
PRIMARY
NSC
46475
Created by admin on Fri Dec 15 16:38:44 UTC 2023 , Edited by admin on Fri Dec 15 16:38:44 UTC 2023
PRIMARY
MESH
C000380
Created by admin on Fri Dec 15 16:38:44 UTC 2023 , Edited by admin on Fri Dec 15 16:38:44 UTC 2023
PRIMARY
EVMPD
SUB07799MIG
Created by admin on Fri Dec 15 16:38:44 UTC 2023 , Edited by admin on Fri Dec 15 16:38:44 UTC 2023
PRIMARY
MERCK INDEX
m5552
Created by admin on Fri Dec 15 16:38:44 UTC 2023 , Edited by admin on Fri Dec 15 16:38:44 UTC 2023
PRIMARY Merck Index
Related Record Type Details
ACTIVE MOIETY